中华临床医师杂志(电子版)
中華臨床醫師雜誌(電子版)
중화림상의사잡지(전자판)
CHINESE JOURNAL OF CLINICIANS(ELECTRONIC VERSION)
2014年
20期
3665-3668
,共4页
糖尿病%糖尿病肾病%乙酰CoA羧化酶
糖尿病%糖尿病腎病%乙酰CoA羧化酶
당뇨병%당뇨병신병%을선CoA최화매
Diabetes mellitus%Diabetic nephropathies%Acetyl-CoA carboxylase
乙酰辅酶 A 羧化酶 B(ACACB)是一种促进脂肪合成的限速酶,在糖脂代谢中起重要作用。研究表明ACACB是影响糖尿病(DM)及糖尿病肾病(DN)发生与发展的危险因素之一,本文就此作简要综述。
乙酰輔酶 A 羧化酶 B(ACACB)是一種促進脂肪閤成的限速酶,在糖脂代謝中起重要作用。研究錶明ACACB是影響糖尿病(DM)及糖尿病腎病(DN)髮生與髮展的危險因素之一,本文就此作簡要綜述。
을선보매 A 최화매 B(ACACB)시일충촉진지방합성적한속매,재당지대사중기중요작용。연구표명ACACB시영향당뇨병(DM)급당뇨병신병(DN)발생여발전적위험인소지일,본문취차작간요종술。
Acetyl-CoA carboxylase beta (ACACB), a rate limited enzyme to promote fatty acid biosynthesis, plays an important role in glucolipid metabolism. Researches have shown that ACACB is one of the risk factors for development of diabetes mellitus (DM) and diabetic nephropathy (DN), which were briefly reviewed in this paper.